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Summary It is known that a region of epithelial dysplasia cannot easily be distinguished
macroscopically from normal looking area surrounding early oral squamous cell carcinoma
(OSCC). In 1953, Slaughter emphasized field cancerization and the importance of examining
the fields surrounding OSCC. Since 1997, we have used vital staining with iodine for detecting
surgical margin and investigated the usefulness of this method. From a pathological point of view,
various types of dysplasia in iodine unstained area (IU) surrounding OSCC was found. In oral
mucosa, iodine—glycogen reaction does not occur in dysplastic mucosa due to the lack of glycogen
granules in the cytoplasm of those cells. This area has high positive PCNA and p53 cells with
malignant potentiality. More recently, since 2010, we have used fluorescence visualization (FV)
with vital staining with iodine. This device can visualize epithelial dysplasia surrounding OSCC as
fluorescence visualization loss (FVL). FVL has high positive Ki-67 and p53 cells with malignant
potentiality. We suggest that FV has delineated various types of dysplasia and the delineation of
surgical margin is the same or better than vital staining with iodine. Moreover, compared to vital
staining with iodine, it is simple to use with no invasion.
# 2013 Japanese Association for Dental Science. Published by Elsevier Ltd. All rights reserved.
* Corresponding author at: Department of Oral and Maxillofacial Surgery, Tokyo Dental College, 1-2-2 Masago, Mihama-ku, Chiba-shi, Chiba
261-8502, Japan. Tel.: +81 43 270 3973; fax: +81 43 270 2046.
E-mail address: tanomura@tdc.ac.jp (T. Nomura).
Available online at www.sciencedirect.com
jou r nal h o mep age: w ww.els evier . co m/lo c ate / jd sr
1882-7616/$ — see front matter # 2013 Japanese Association for Dental Science. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.jdsr.2013.04.001
4.1. A clinical study about the comparison between FVL and IU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4.2. The expression of ki-67 and p53 in the area of FVL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
5. Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
Detection of field alterations for oral squamous cell carcinoma 1071. Introduction
Oral squamous cell carcinoma (OSCC) is a major health
problem worldwide, accounting for 274,000 new cases and
145,000 deaths annually [1]. In Japan, it is estimated that
there will be 6900 new cases of OSCC in 2005 [2]. Further-
more, there is definitely an increasing number of OSCC as a
result of Japan’s aging society [3]. The conventional treat-
ment of early OSCC is surgery, however, early OSCC patients
sometimes recurred after radical resection. When surgeons
try to remove early OSCC, a region of epithelial dysplasia
cannot easily be distinguished macroscopically from normal
looking area surrounding OSCC. Leaving this epithelial dys-
plasia unresected can often result in local recurrence or
second primary tumors (SPTs). This may result in the recur-
rence of carcinomas at the primary site. From a clinical point
of view, it may lead to SPTs to establish not only the histology
but also the molecular change of the surgical margin. It is
likely that SPTs is a result of accumulated genetic changes
present in the histologically normal epithelium of the surgical
margin [4]. Thus, in contrast to advanced OSCC, some
patients with early OSCC who were considered curable even-
tually suffered from locoregional failure after radical resec-
tion. The present article reviews our current understanding
on some methods for detecting a safety margin, including
field alteration surrounding early OSCC.
2. Field alternations surrounding OSCC
(Slaughter’s concept)
Slaughter reported about his concept of field cancerization,
when studying OSCC in 1953 [5]. He emphasized the impor-
tance of examining the field surrounding OSCC for both risk
assessment and management of this disease. By performingFigure 1 The concept of field cancerization [5]. The epithelial dy
recurrence or a second primary cancer. It is not clear to detect outextensive histological examinations, he proposed a concept
describing issues covered by the term field cancerization as
follows (Fig. 1);
a. OSCC develops in multifocal areas of precancerous
change;
b. Abnormal tissue surrounds the tumor;
c. Oral cancer often consists of multiple independent
lesions that sometimes coalesce;
d. The persistence of abnormal tissue after surgery may
explain SPTs and local recurrences.
It is well known that an accumulation of genetic altera-
tions forms the basis for the progression from a normal cell to
a cancer cell, referred to as the process of multistep carci-
nogenesis (Fig. 2). Slaughter suggested that OSCC develops in
the following order; from oral premalignant lesions, which is
hyperplasia; to mild dysplasia; then to moderate dysplasia;
and to severe dysplasia; then into carcinoma in situ (CIS); and
finally to invasive SCC. WHO advocated that mild and mod-
erate dysplasia as low grade dysplasia and severe dysplasia
and carcinoma in situ as high grade dysplasia [6]. Braakhuis
et al. reported that the presence of allelic loss at 3p and 9p is
associated with an increased cancer risk. Additional losses at
17p increased cancer risk dramatically [7]. The process of
field cancerization can be defined in these allelic losses, and
its position in the process of multistep carcinogenesis can be
delineated. Furthermore, some reports indicated that the
presence of a field change with genetically altered cells is a
distinct biological stage in malignant potential with impor-
tant clinical implications [4,7—11]. Thus, we suggest that
various types of dysplasia surrounding OSCC have to be
removed completely. However, these mechanisms remain
unclear and it is important to establish the method of detect-
ing safety margin in early OSCC.splasia often observed around SCC is considered to cause local
line of this abnormal area by the naked eye (arrow).
Figure 2 Multistep carcinogenesis of oral malignancy (Slaughter’s concept [5]).
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detecting field alternations
As described in Slaughter’s concept, a region of epithelial
dysplasia surrounding early OSCC have to be delineated and
removed. Since 1997, we have performed not only conven-
tional resection but also iodine staining method for patients
with early OSCC. Iodine staining of mucosal lesions was first
reported by Schiller who used it to identify cervical cancer of
the uterus [12]. Thereafter, this method has been employed
for the upper gastrointestinal tract [13—15]. Epstein et al.
reported that possible patients of oral premalignant lesions
and early oral cancers used vital staining with iodine, and the
result of sensitivity was 92.5% and specificity 63.2% [16,17].
Kurita et al. observed that vital staining with iodine is a useful
method for identifying malignant lesions and lesions with the
possibility of malignancy in Japan [17].
3.1. Comparison between resection of no vital
staining and of vital staining with iodine
Since 1982, we have established that a clear margin is defined
as the distance from the invasive tumor front that is 10 mm or
more from the resected margin, as conventional resection in
our clinic (Fig. 3). After that, since 1997, we have used vital
staining with 3% iodine solution to decide the surgical margin.Figure 3 History of the detection of surgicalCurrently, to delineate safety margin in early OSCC, our clinic
uses the combination of fluorescence visualization and vital
staining with iodine to detect epithelial dysplasia.
With vital staining with iodine, we resected tumor to detect
surgical margin of 5 mm distance from iodine unstained area
(IU) (Fig. 4). The purpose of our study was to determine the
usefulness of vital staining with iodine in deciding the surgical
margin. One hundred and two patients diagnosed with T1 and
early T2 OSCC between 1987 and 2006 were selected at the
Department of Oral and Maxillofacial Surgery, Tokyo Dental
College. We have already gotten an official approval from the
ethical committee of Tokyo Dental College. We classified the
patients into two categories as follows: Group 1, where no
iodine staining was carried out, all treated between January
1987 and December 1996 (41 cases); and Group 2, where
iodine-staining was carried out, all treated between January
1997 and December 2007 (61 cases). We compared clinical and
pathological histories between these two groups. First, in
positive rates of second primary cancers, the results revealed
that patients in Group 1 (17.1%) were significantly higher than
those in Group2 (4.9%) (Fig. 5A). Next, in positive rates of
pathological findings of surgical margin, the epithelial dyspla-
sia-positive rate in Group 1 (26.8%) was higher than that in
Group 2 (8.2%) (Fig. 5B). Finally, there were surgical margin-
positive in 2 cases in Group 1 (4.9%). We suggest that the iodine
staining method is a useful tool in deciding surgical margin in
early OSCC. margin for early oral cancer in our clinic.
Figure 4 Case of early T2 tongue cancer. We resected tumor to detect surgical margin of 5 mm distance from iodine unstained area.
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A histochemical and ultrastructural study on the localization
of glycogen in normal and hyperkeratotic oral epithelium in
humans has demonstrated that glycogen content is inversely
related to the degree of keratosis, suggesting a role for
glycogen in keratinization [18]. Basically, normal tissue
would stain brown, while proliferating epithelium would
be unstained or would stain poorly [19]. However, there
are few reports on the investigation of IU and malignant
potentiality. To clarify the correlation between IU and
epithelial dysplasia, we examined the existence of glycogen
and changes in Proliferating Cell Nuclear Antigen (PCNA) in
tumor suppressor gene expression (p53) in the dysplastic
epithelium using immunohistochemical and ultrastructural
methods. Subjects are thirty cases of T1 and early T2 OSCC.
Based on the WHO classification (2005), we classified the
epithelial dysplasia histopathologically into thirty specimens
with normal mucosa, twenty specimens with mild, twenty
three specimens with moderate and twenty three specimens
with severe epithelial dysplasia from thirty cases [6]. There
were no significant differences between the normal epithe-
lium (43.0%) and the mild dysplasia (45.5%) in terms of the
ratios of PAS positive cells and their distribution (Fig. 6 and
Table 1). However, PAS staining area of the moderate and
severe dysplasia (13.9%) decreased more significantly than
those of the normal epithelium (p < 0.01). Furthermore, the
distribution and the ratio of PCNA- and p53-positive cells inFigure 5 Comparison between resection of no vital staining and o
tumors and (B) positive rate of pathological findings of surgical marg
1987 and December 1996 (41 cases). Group 2 was treated with iodinethe moderate (31.1%, 36.0%) and severe dysplasia groups
(41.5%, 41.8%) were significantly higher than in normal
epithelium and mild dysplasia ( p < 0.01) (Fig. 7 and Table
1). In electron microscopic observations, glycogen granules
were seen in the cells of normal epithelium but were not seen
in the cells of IU (Fig. 8). In conclusion, IU surrounding OSCC
has various types of dysplasia. In oral mucosa, iodine—glyco-
gen reaction does not occur in dysplastic mucosa due to the
lack of glycogen granules in the cytoplasm of those cells. This
area has high positive PCNA and p53 cells with malignant
potentiality. Therefore, from the standpoint of molecular
biology, we suggest iodine-staining method as strongly useful
tool in defining the region of epithelial dysplasia. On the
other hand, we are always unable to see a clear margin with
IU. It is known that keratinized squamous epithelia, such as
the gingiva and the hard palate, were less reactive to iodine.
Iodine—glycogen reaction does not occur in epithelial cells
with chronic inflammatory change. Furthermore, we some-
times suffer from drug induced reaction such as iodine
hypersensitivity. For this reason, we must look for a more
convenient and useful tool for the detection of safety margin.
4. Optically guided surgical approach and
the outcome of early OSCC
More recently, Pierre et al. have introduced an approach
using fluorescence visualization (FV) technology, fluorescencef vital staining with iodine. (A) Positive rate of second primary
in Group 1 was treated without iodine-staining between January
-staining between January 1997 and December 2007 (61 cases).
Figure 6 PAS staining for iodine unstained area (10). (A) Normal epithelium with H—E staining, (B) normal epithelium with PAS
staining, (C) iodine unstained area with H—E staining and (D) iodine unstained area with PAS staining.
110 T. Nomura, T. Shibaharaimaging device, and VELscope (LED Dental Inc., White Rock,
British Colombia, Canada [19]) (Fig. 9). This simple handheld
device uses a blue light (400—460 nm) to illuminate a collagen
matrix or a flavin adenine dinucleotide (FAD). A selective filter
in the eyepiece allows the viewer to directly visualize the pale
green autofluorescence that is given off by normal tissue
(fluorescence visualization retention, FVR). On the other
hand, abnormal tissue shows decreased autofluorescence
and appears as a dark brown in comparison with green sur-
rounding normal tissue. This dark brown is the so called
fluorescence visualization loss (FVL). FVL is caused by absorb-
ing a specific blue light due to the breakdown of the collagen
matrix and decrease in FAD. The oxidized form of FAD is
important fluorophores that are good indicators of cellular
metabolism. It has been shown that fluorescence intensity due
to FAD decreases with dysplastic progression. We have sug-
gested this device as a suitable adjunct for margin delineation
since 2010. Therefore we investigated to evaluate the detec-
tion of surgical margin comparison between FV and vitalTable 1 Positive ratios of PAS, PCNA, and p53 staining with vari
Site n Ratios of PAS positiv
cells (%)
Control (normal epithelium) 30 43.0 
Mild dysplasia 20 45.5 
Moderate dysplasia 23 13.9 *
Severe dysplasia 23 3.9 *
* p < 0.01 (vs control).staining with iodine, and the accuracy of autofluorescence
examination in its ability to delineate high-risk oral mucosal
lesions.
4.1. A clinical study about the comparison
between FVL and IU
To clarify the usefulness of FV compared to vital staining with
iodine, we investigated surgical margin of early OSCC in
comparison between FVL and IU. Thirty one cases of T1
and early T2 OSCC patients were examined in this study.
At the time of surgery, the operating surgeon outlined the
boundary with vital staining with iodine and fluorescence
visualization. With the operating room lights off, we exam-
ined the lesion and outlined the FVL, measured its size, and
recorded data on the surgical tracking sheet. Moreover, we
used vital staining with iodine and considered in comparison
between FVL and IU, and we resected according to the wider
boundary of the outline. As a result, the entire area by FVLous dysplasia.
e Ratios of PCNA positive
cells (%)
Ratios of p53 positive
cells (%)
19.6 5.8
21.6 7.3
31.1 36.0 *
41.5 41.8 *
Figure 7 Immunohistochemical staining for iodine unstained area. (A) Normal epithelium with PCNA staining, (B) normal epithelium
with p53 staining, (C) iodine unstained area with PCNA staining and (D) iodine unstained area with p53 staining.
Detection of field alterations for oral squamous cell carcinoma 111showed various types of epithelial dysplasia (Fig. 10). There
were no normal epithelium cells in any of the FVL regions.
Furthermore, the ratio of various types of dysplasia is almost
equal between FVL (mild 28.6%, moderate 61.9%, severe
9.5%) and IU (mild 35.3%, moderate 58.8%, severe 5.9%).
However, one case of carcinoma of tongue (T1N0M0) showedFigure 8 Electron microscopic observations. (A) Normal epithel
desmosomes; Tf: tonofilaments; N: Nucleus; bar = 1 mm. Glycogen 
normal epithelium.local recurrence after surgery guided FVand underwent more
surgery. In delineating ratio of FVL and IU into thirty one early
OSCC cases, twenty seven cases of FVL (87.1%) were same as
or a little higher than IU (71.0%) (Table 2). We considered that
determining the surgical margin based on results of FV would
not lead to over surgery, and could help prevent SPTs.ium cell, (B) iodine unstained cell, G: glycogen granules; D:
granules are not visible in moderate dysplasia compared with
Figure 9 Fluorescence visualization (VELscopeTM). Abnormal tissue shows decreased autofluorescence and appears as dark brown.
This dark brown is the so called fluorescence visualization loss (FVL). (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
112 T. Nomura, T. Shibahara4.2. The expression of ki-67 and p53 in the area
of FVL
To elucidate malignant potentiality in FV area, some cases of
early OSCC were examined in this study. These materials
were obtained from the department of Oral and Maxillofacial
Surgery at Tokyo Dental College. Surgical margin wereFigure 10 The incidence of various dysplasia for surgical
margin detected with FVL or IU.determined at about 5 mm outside the area of FVL. A super-
ficial incision was made with a surgical blade along the
boundary line of FVL to mark the clinical borderline within
the mucosa. We examined expression of Ki-67 and p53 in the
area of FVL by means of immunohistochemical methods from
these samples. Although these samples are not enough,
positive cells of Ki-67 and p53 seemed to strongly express
within the area of FVL with epithelial dysplasia surrounding
OSCC (Figs. 11 and 12). On the contrary, Ki-67 and p53 were
hardly seen in epithelial tissue out of margin. Therefore, we
suggest that FVL has malignant potentiality and FV guided
surgical margin might not only be adequate but also to be
able to help prevent SPTs genetically.
5. Discussion
Various types of dysplasia surrounding OSCC looks like a
normal oral mucosa. Taking margins that are too large cause
severe cosmetic and functional morbidity and margins thatTable 2 Delineating ratio of dysplasia detected with FVL or
IU.
Diagnosis Cases (n) FVL IU
Low grade dysplasia 28 24 20
High grade dysplasia 3 3 2
Dysplasia 31 27 22
Delineating ratio (%) 87.1 71.0
FVL: fluorescence visualization; IU: iodine unstained area.
Figure 11 The expression of ki-67 in the area of FVL. C: cutting off margin of FVL; FVL: fluorescence visualization loss; FVR:
fluorescence visualization retention.
Detection of field alterations for oral squamous cell carcinoma 113are too small may leave cancerous tissue behind, as evi-
denced by frequent positive surgical margins and high locor-
egional recurrence. The NCCN Clinical Practice Guidelines in
Oncology (NCCN Guidelines) allows many systemic therapy
options for patients with oral cavity cancer in 2012 [20].
NCCN guideline suggested that a margin of at least 5 mm ofFigure 12 The expression of p53 in the area of FVL. C: cutting
fluorescence visualization retention.histologically normal epithelium in the surgical specimen is
traditionally regarded as the standard in the treatment of
OSCC. Conversely, some reported that such an approach still
fails to completely remove the field alterations surrounding
OSCC [21—26]. Kurita et al. have also proposed that a 5 mm
border of normal tissue peripheral to the iodine positive area off margin of FVL; FVL: fluorescence visualization loss; FVR:
114 T. Nomura, T. Shibaharawould be adequate for the complete removal of the dysplas-
tic epithelium [17]. We have been successful in improving the
outcome of the incident of SPTs with the use of iodine-
staining method in deciding the margin. PCNA and p53 are
known as markers for the malignant potential of the oral
mucosa; and PCNA is valuable as a marker to judge biological
malignancy and proliferation [27—30]. The p53 mutant gene
plays a significant role in malignant transformation [27,31—
37]. The positive ratio of PCNA and p53 in moderate and
severe dysplasia were higher. We surmise that a mutant p53
appears in the epithelial dysplasia such as an IU area. We are
able to obtain the evidence of vital staining with iodine as
useful tool for identifying malignant potential tissue sur-
rounding early OSCC. On the other hand, vital staining with
iodine produces a brown stain as a result of the reaction of
iodine with glycogen. Iodine solution was usually prepared
using 1—5% or Lugol’s solution [16,17,37,38]. We have always
used 3% iodine solution. However, this method does not allow
us to see a clear margin. Epstein et al. and Silverman pointed
out that keratinized squamous epithelia or inflammation
tissue were less reactive to iodine and useless [16,18]. These
problems may limit the use of iodine solution. Thus, simple
device, FV may make up for the shortcomings of iodine
staining method. It is likely that this device has delineated
various types of dysplasia and delineation of surgical margin
is the same or more than vital staining with iodine. It is simple
to use and no invasion is seen, compared to vital staining with
iodine. This device was reported to achieve a sensitivity of
98% and specificity of 100% when discriminating normal
mucosa from severe dysplasia/carcinoma in situ or invasive
carcinoma [39]. Pierre et al. envisaged this device as a
suitable adjunct for oral cancer screening, biopsy guidance,
and margin delineation [19,39]. In the resection specimen
with cancer or precancerous lesions, microsatellite analysis
of LOH at 3p, 9p and 17p was done, and the area of FVL
showed higher rates of LOH in all categories significantly [39].
These results are likely to be similar to Slaughter’s concept.
Meanwhile some controversy exists. Awan et al. reported
that this device demonstrated a relatively high sensitivity
(84%) and low specificity (15%) in discriminating high risk
dysplasia from benign lesions and was not enough for detec-
tion of early diagnosis [40]. Both vital staining with iodine and
FV has completely different mechanisms. When FVL is
detected only by VELscope, this lesion would need a careful
consideration because of the absence of clinical evidence.
Today, as far as this device is concerned, the detection of
surgical margin using both FV and vital staining with iodine
would be better. In the near future, we will need to inves-
tigate about the usefulness of FV with more data.
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